KEYNOTE-676 cohort A: pembrolizumab plus BCG in recurrent HR NMIBC



Neal Shore, MD, FACS, Carolina Urologic Research Center, Myrtle Beach, SC, gives an overview of the Phase III KEYNOTE-676 …

source

Leave a Reply

Your email address will not be published. Required fields are marked *

Amazon Affiliate Disclaimer

Amazon Affiliate Disclaimer

“As an Amazon Associate I earn from qualifying purchases.”

Learn more about the Amazon Affiliate Program